Literature DB >> 7838890

Lithium addition in endogenous depressions resistant to tricyclic antidepressants or related drugs: relation to the status of the pituitary-thyroid axis.

J Schöpf1, T Lemarchand.   

Abstract

Concentrations of TSH, TRH-induced TSH (delta-TSH), T4, FT4, T3, and FT3 were investigated in 20 patients resistant to antidepressants before and after one week of lithium addition. TSH and delta-TSH increased, whereas FT4 and FT3 decreased statistically significantly during this treatment, indicating a slight lithium-induced hypothyroid function. A statistically significant correlation between improvement and the FT3/FT4 ratio after seven days of lithium addition was found. Also, an increase or only a small decrease in FT3 and an augmenting FT3/FT4 ratio during lithium addition were correlated with a favorable outcome. Besides the possibility that a high relative FT3 concentration is an indicator of an unknown somatic condition favorable for improvement, this finding might be directly related to treatment response. It appears conceivable that even within the normal range a sufficient T3 concentration is necessary for an optimal response to lithium addition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7838890     DOI: 10.1055/s-2007-1014304

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  2 in total

Review 1.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

2.  Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression.

Authors:  Tom Bschor; Christopher Baethge; Mazda Adli; Ute Lewitzka; Uta Eichmann; Michael Bauer
Journal:  J Psychiatry Neurosci       Date:  2003-05       Impact factor: 6.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.